Viewing Study NCT06487559


Ignite Creation Date: 2025-12-24 @ 2:41 PM
Ignite Modification Date: 2026-01-05 @ 12:41 AM
Study NCT ID: NCT06487559
Status: RECRUITING
Last Update Posted: 2025-03-04
First Post: 2024-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module